Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases.
about
Emerging therapeutic options for sporadic inclusion body myositisMovement and Other Neurodegenerative Syndromes in Patients with Systemic Rheumatic Diseases: A Case Series of 8 Patients and Review of the LiteratureBiomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory MyopathiesImmunotherapies for Immune-Mediated Myopathies: A Current PerspectiveImmune and myodegenerative pathomechanisms in inclusion body myositisDevelopment and evaluation of a standardized ELISA for the determination of autoantibodies against cN-1A (Mup44, NT5C1A) in sporadic inclusion body myositis.Myositis Mimics.Pathomechanisms of anti-cytosolic 5'-nucleotidase 1A autoantibodies in sporadic inclusion body myositis.Sporadic inclusion body myositis - a myodegenerative disease or an inflammatory myopathy.Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis.Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum.Integrated classification of inflammatory myopathies.Idiopathic inflammatory myopathies overlapping with systemic diseases.Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis.New ways to subclassify patients with myositis.Cytokine Profiling of Serum Allows Monitoring of Disease Progression in Inclusion Body Myositis.Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?Inclusion body myositis pathogenesis: Steady progress.Current Classification and Management of Inflammatory Myopathies.Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus.Bench to bedside review of myositis autoantibodies.
P2860
Q26786571-402723A7-A8EE-45A6-87CA-6FF7D247C251Q26801152-F7326B05-6096-4CBA-9544-4F5F57DBDA96Q26824432-156548C3-A522-4011-A711-AB445295926FQ30699742-BBBA1CBD-B059-4D99-9882-34A8735A4C8CQ33753870-D4F4DD50-D974-4A8B-A913-7AE4BC493581Q37421042-15AD65E2-C49B-457B-A6D9-9F7F38DDBCEFQ38569863-B4AAE70D-41B3-430E-9AA8-3E6F71709E9EQ38711585-2D0C763A-FD0B-4B77-83A1-4DA1F0938D3CQ38767200-E7C40F4D-9622-4338-94E6-961ABE945C91Q38999120-93FF9CD6-0F39-49F4-A20C-F29000A33942Q39021882-512F9B90-E63B-4EAF-A64A-E535CB4DDF7BQ39027323-C57A745C-355F-4C51-B95E-CAD5FA65CC1CQ47401892-226D604F-305A-4BFF-A781-47FC766A60CFQ47648163-849D3704-00DD-4F1C-B494-5424988421E9Q47868107-AD170FBC-EB3B-44AD-A655-58303E8D76ABQ48539566-9634A07D-BF9C-40D3-88C8-B7873E9E94A7Q52597638-5D187CA7-0C3B-4701-A135-9A20DAF79ED3Q54645632-04BFAE4F-D1DA-4DB3-AC1F-5F6F718C46E2Q54977148-19274476-739D-45A0-9DB2-3663655B7381Q55196540-1E3656D8-40F4-46CB-AA69-7F4F94C54890Q55425108-238C2158-5411-4F31-8168-27E286350028
P2860
Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Disease specificity of autoant ...... sus known autoimmune diseases.
@ast
Disease specificity of autoant ...... sus known autoimmune diseases.
@en
type
label
Disease specificity of autoant ...... sus known autoimmune diseases.
@ast
Disease specificity of autoant ...... sus known autoimmune diseases.
@en
prefLabel
Disease specificity of autoant ...... sus known autoimmune diseases.
@ast
Disease specificity of autoant ...... sus known autoimmune diseases.
@en
P2093
P2860
P50
P1476
Disease specificity of autoant ...... sus known autoimmune diseases.
@en
P2093
Ger J M Pruijn
Judith Stammen-Vogelzangs
Lenka Plestilova
Mark Roberts
Michael G Hanna
Robert G Cooper
P2860
P304
P356
10.1136/ANNRHEUMDIS-2014-206691
P407
P50
P577
2015-02-24T00:00:00Z